title: Successful treatment of a brain-metastasized renal cell carcinoma.
abstract: Renal cell carcinoma is an uncommon type of cancer that rarely metastasizes to the brain. The prognosis after discovering brain metastasis has traditionally been dismal. We are presenting a case of renal cell carcinoma with multiple brain metastases that was successfully treated with multimodal therapy including a new type of medication.
authors.affiliation: Medical Center of Central Georgia, Macon, GA, USA. mswalid@yahoo.com
authors.forename: M Sami
authors.initials: MS
authors.lastname: Walid
authors.forename: Kim W
authors.initials: KW
authors.lastname: Johnston
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000556:secondary / Q000628:therapy*; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D009536:Niacinamide / Q000031:analogs & derivatives; D010296:Parietal Lobe; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use*; D018714:Radiotherapy, Adjuvant; D040262:Receptors, Vascular Endothelial Growth Factor; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib; D040262:Receptors, Vascular Endothelial Growth Factor